Aliment Pharmacol Ther

1. RUBIN DE CELIX C, Chaparro M, Gisbert JP
   Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel Disease. Authors' Reply.
   Aliment Pharmacol Ther. 2025 Sep 17. doi: 10.1111/apt.70379.
   

   >> Share

   
   
2. CLARK N, Tassone D, Ding NS
   Editorial: Managing the Moving Target-Dose Adjustments in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Sep 17. doi: 10.1111/apt.70340.
   

   >> Share

   
   
3. NATT N, Gindi M, Dela Cruz GR, Ponich T, et al
   IL23 Receptor Polymorphism Is a Predictor of Anti-Tumour Necrosis Factor-alpha-Induced Paradoxical Psoriasis in Inflammatory Bowel Disease.
   Aliment Pharmacol Ther. 2025 Sep 16. doi: 10.1111/apt.70377.
   

   >> Share

   
   
4. NORDESTGAARD RLM, Lo B, Bergstrom R, Adzioski I, et al
   Clinical Trial: Evaluating a Single 1600 mg Tablet Regimen of 5-Aminosalicylate for Ulcerative Colitis-The EASI Trial.
   Aliment Pharmacol Ther. 2025 Sep 16. doi: 10.1111/apt.70375.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

5. PANACCIONE R, Melmed GY, Drobne D, Kaur M, et al
   Impact of Extended Risankizumab Treatment in Patients With Ulcerative Colitis Who Did Not Respond to Induction Treatment.
   Clin Gastroenterol Hepatol. 2025 Sep 13:S1542-3565(25)00797.
   

   >> Share

   
   
6. PRENTICE R, Burns M, Bell SJ
   Novel tools for assessment of neurocognitive outcomes in infants born to women with inflammatory bowel disease.
   Clin Gastroenterol Hepatol. 2025 Sep 13:S1542-3565(25)00794.
   

   >> Share

   
   
7. WEWER MD, Soderling J, Ludvigsson JF, Myrelid P, et al
   Early ileocecal resection or tumor necrosis factor inhibitor in Crohn's disease: Replication in a Swedish cohort.
   Clin Gastroenterol Hepatol. 2025 Sep 11:S1542-3565(25)00762.
   

   >> Share

   
   

   
   Dig Dis Sci

8. SACHAR M, Rojanasopondist P, Beaty W, Fernandez C, et al
   Safety and Efficacy of Ustekinumab and Vedolizumab Among Older Adults with Inflammatory Bowel Disease.
   Dig Dis Sci. 2025 Sep 16. doi: 10.1007/s10620-025-09395.
   

   >> Share

   
   
9. NGUYEN B, Quon S
   Is Inflammatory Bowel Disease a Risk Factor for Perforation During Diagnostic Colonoscopy? A Systematic Review and Meta-Analysis.
   Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09392.
   

   >> Share

   
   
10. KUCHA P, Rawa T, Kiljan J, Zagorowicz E, et al
    Severe Primary Epstein-Barr Virus Infection in a Young Female with Crohn's Disease Treated with Upadacitinib.
    Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09391.
    

    >> Share

    
    
11. LUO M, Ye L, Ju J, Li Z, et al
    Rectal Metastasis Mimicking Inflammatory Bowel Disease.
    Dig Dis Sci. 2025 Sep 13. doi: 10.1007/s10620-025-09381.
    

    >> Share

    
    

    
    Scand J Gastroenterol

12. MARLICZ W, Skonieczna-Zydecka K, Loniewski I, Koulaouzidis A, et al
    Rethinking iron therapy in IBD: integrating the microbiota perspective.
    Scand J Gastroenterol. 2025;60:817-819.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share